Evidence map›Paper›PMID 30247125›Full record

ReviewIET nanobiotechnology2018

Biosynthesis of bimetallic and core-shell nanoparticles: their biomedical applications - a review.

Mehrdad Khatami, Hajar Q Alijani, Iraj Sharifi

Abstract readReview
In one paragraph

Review in IET nanobiotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Biosynthesis of Ag nanoparticles usingElectronic physician · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mehrdad KhatamiLeishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Hajar Q AlijaniNanoBioElectrochemistry Research Center, Bam University of Medical Sciences, Bam, Iran.
Iraj SharifiResearch Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran. iraj.sharifi@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, researchers succeeded in designing and manufacturing a new class of nanoparticles (NPs) called hybrid NPs. Among hybrid NPs, bimetallic and core-shell NPs were a revolutionary step in NPs science. A large number of green physiochemical and methods for nanostructures synthesis have been published. Eventually, physiochemical methods are either expensive or require the use of chemical compounds for the synthesis of bimetallic and core-shell nanostructures. The main challenges that scientists are facing are making the process cheaper, facile and eco-friendly efficient synthesis process. Green synthesis (biosynthesis) refers to the use of bio-resources (such as bacteria, fungi, plants or their derivatives) for the synthesis of nanostructures. The popularity of the green synthesis of nanostructures is due to their environmental friendliness and no usage of toxic materials, environmental friendliness for the synthesis or stability of nanostructure. Bimetallic and core-shell NPs have many biomedical applications such as removing heavy metals, parasitology, molecular and microbial sensor, gene carrier, single bacterial detection, oligonucleotide detection and so on. The purpose of this study is to discuss briefly the biosynthesised bimetallic and core-shell NPs, their biomedical applications.

Indexed as

Metal NanoparticlesNanomedicineAnimalsHumansParticle Size

Identifiers

PMID30247125
PMCPMC8676289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.